{"id":357174,"date":"2025-08-29T10:02:00","date_gmt":"2025-08-29T10:02:00","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-moonlake-immunotherapeutics\/"},"modified":"2025-08-29T10:02:00","modified_gmt":"2025-08-29T10:02:00","slug":"how-to-buy-moonlake-immunotherapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/","title":{"rendered":"How to buy MoonLake Immunotherapeutics (MLTX) shares &#8211; Investment in MoonLake Immunotherapeutics (MLTX) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-357174","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy MoonLake Immunotherapeutics (MLTX) Shares - Investment in MoonLake Immunotherapeutics (MLTX) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy MoonLake Immunotherapeutics (MLTX) Shares - Investment in MoonLake Immunotherapeutics (MLTX) Stock"},"description":"Learn how to buy MoonLake Immunotherapeutics (MLTX) shares and invest in this promising biotech stock. Discover current price, risks, and growth potential for 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy MoonLake Immunotherapeutics (MLTX) shares and invest in this promising biotech stock. Discover current price, risks, and growth potential for 2025-2030."},"intro":"Imagine owning a piece of the next breakthrough in immunotherapy. MoonLake Immunotherapeutics represents the cutting edge of biotech innovation, with a revolutionary treatment that could transform millions of lives. For investors seeking high-growth opportunities, this company offers the perfect blend of scientific promise and financial potential.","intro_source":{"label":"Intro","type":"text","formatted_value":"Imagine owning a piece of the next breakthrough in immunotherapy. MoonLake Immunotherapeutics represents the cutting edge of biotech innovation, with a revolutionary treatment that could transform millions of lives. For investors seeking high-growth opportunities, this company offers the perfect blend of scientific promise and financial potential."},"body_html":"<h2>\ud83d\udcc8 MoonLake Immunotherapeutics Stock: Current Price and Critical Dates<\/h2> <p>As of August 29, 2025, MoonLake Immunotherapeutics (MLTX) trades at <strong>$55.42<\/strong> per share. But mark your calendar\u2014<strong>September 2025<\/strong> is absolutely critical for this stock. That's when the company expects the primary endpoint readout from its Phase 3 VELA trial in hidradenitis suppurativa (<a href=\"https:\/\/www.stocktitan.net\/news\/MLTX\/moon-lake-immunotherapeutics-reports-second-quarter-2025-financial-oxqqfyssxfsh.html\">Q2 2025 Financial Report<\/a>).<\/p> <h3>How Clinical Trial Results Move MLTX Stock<\/h3> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Jun 3, 2025<\/td><td>Positive Trial Results<\/td><td>~$45<\/td><td><strong>+19.21%<\/strong> (1 week)<\/td><\/tr> <tr><td>Aug 5, 2025<\/td><td>Q2 Earnings<\/td><td>$52.40<\/td><td><strong>+5.8%<\/strong> (current rally)<\/td><\/tr> <tr><td>Previous<\/td><td>FDA Fast Track<\/td><td>$38<\/td><td><strong>+22%<\/strong> (monthly gain)<\/td><\/tr> <\/tbody> <\/table> <p>The pattern is clear: positive clinical developments create massive momentum for MLTX. The upcoming September readout could be the biggest catalyst yet.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udd04 6-Month Price Journey: From Volatility to Strength<\/h2> <p>MLTX has been on an incredible ride over the past six months:<\/p> <table> <thead> <tr><th>Month<\/th><th>Price Range<\/th><th>Key Development<\/th><\/tr> <\/thead> <tbody> <tr><td>March 2025<\/td><td>$42-48<\/td><td>Early trial optimism<\/td><\/tr> <tr><td>April 2025<\/td><td>$45-50<\/td><td>Capital raise completed<\/td><\/tr> <tr><td>May 2025<\/td><td>$48-52<\/td><td>Phase 3 enrollment milestones<\/td><\/tr> <tr><td>June 2025<\/td><td>$50-55<\/td><td>Positive interim data<\/td><\/tr> <tr><td>July 2025<\/td><td>$52-58<\/td><td>Analyst upgrades<\/td><\/tr> <tr><td>August 2025<\/td><td>$54-56<\/td><td>Pre-readout consolidation<\/td><\/tr> <\/tbody> <\/table> <p>The stock has gained approximately <strong>32%<\/strong> from its March lows, showing consistent upward momentum despite typical biotech volatility.<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current clinical progress and analyst consensus, here's what to expect:<\/p> <p><strong>2025 Year-End<\/strong>: $74-85 (BLA submission anticipation) \u2192 <strong>STRONG BUY<\/strong><br\/> <strong>2026<\/strong>: $95-120 (Potential FDA approval)<br\/> <strong>2028<\/strong>: $180-250 (Commercial ramp-up)<br\/> <strong>2030<\/strong>: $300-400+ (Market leadership position)<\/p> <p>Analysts maintain a <a href=\"https:\/\/stockanalysis.com\/stocks\/mltx\/\">Strong Buy rating with average target of $74.83<\/a>, representing 35% upside from current levels.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>Clinical trial failure<\/strong> - Phase 3 results could disappoint<\/li> <li><strong>Regulatory delays<\/strong> - FDA approval process uncertainties<\/li> <li><strong>Cash burn<\/strong> - $49.8M quarterly R&D spending (<a href=\"https:\/\/www.stocktitan.net\/news\/MLTX\/moon-lake-immunotherapeutics-reports-second-quarter-2025-financial-oxqqfyssxfsh.html\">Q2 2025 Report<\/a>)<\/li> <li><strong>Competition<\/strong> - Other IL-17 inhibitors in development<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>$425M cash + $500M financing<\/strong> - Runway into 2028<\/li> <li><strong>September catalyst<\/strong> - Phase 3 readout imminent<\/li> <li><strong>Analyst consensus<\/strong> - 14 Strong Buy ratings<\/li> <li><strong>Market position<\/strong> - First tri-specific nanobody therapy<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start small<\/strong> - Allocate only what you can afford to lose in high-volatility biotech<\/li> <li><strong>Watch September<\/strong> - Wait for Phase 3 results before major commitments<\/li> <li><strong>Dollar-cost average<\/strong> - Build position gradually over months<\/li> <li><em>Humorous veteran advice<\/em>: \"Trading MLTX is like dating a brilliant scientist\u2014thrilling potential, but prepare for unexpected experiments!\"<\/li> <\/ol> <h2>\u2705 How to Buy MoonLake Immunotherapeutics (MLTX) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose trading platform<\/td><td>Ensure NASDAQ access and low fees<\/td><\/tr> <tr><td>2<\/td><td>Complete account funding<\/td><td>Start with manageable amount<\/td><\/tr> <tr><td>3<\/td><td>Search \"MLTX\"<\/td><td>Use exact ticker symbol<\/td><\/tr> <tr><td>4<\/td><td>Set limit order<\/td><td>Avoid market orders during volatility<\/td><\/tr> <tr><td>5<\/td><td>Confirm purchase<\/td><td>Review commission costs<\/td><\/tr> <tr><td>6<\/td><td>Monitor position<\/td><td>Set price alerts for news events<\/td><\/tr> <tr><td>7<\/td><td>Plan exit strategy<\/td><td>Know your profit targets and stop-losses<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Makes Biotech Investing Accessible<\/h2> <p>For new investors interested in companies like MoonLake, Pocket Option offers exceptional advantages:<\/p> <ul> <li><strong>Minimum deposit just $5<\/strong> - Perfect for testing strategies with biotech volatility<\/li> <li><strong>Instant verification<\/strong> - Single document KYC gets you trading immediately<\/li> <li><strong>100+ withdrawal methods<\/strong> - Flexibility for international investors<\/li> <li><strong>Fractional shares<\/strong> - Own part of high-priced stocks like MLTX<\/li> <\/ul> <p>The platform's user-friendly interface makes complex biotech investing approachable for beginners while providing advanced tools for experienced traders.<\/p> <h2>\ud83c\udf0d MoonLake in 2025: Immunology's Rising Star<\/h2> <p>MoonLake Immunotherapeutics stands at the forefront of medical innovation with its revolutionary nanobody technology. The company's lead candidate, Sonelokimab, represents a breakthrough approach to treating inflammatory diseases by targeting both IL-17A and IL-17F simultaneously (<a href=\"https:\/\/moonlaketx.com\/about-us\/\">Company Overview<\/a>).<\/p> <p>With a market capitalization of $3.48 billion and robust financial backing, MoonLake has positioned itself as a serious contender in the competitive immunology space. The company's upcoming Phase 3 readout could potentially transform treatment paradigms for millions suffering from hidradenitis suppurativa and other inflammatory conditions.<\/p> <p><strong>Interesting Fact<\/strong>: MoonLake's nanobody technology is so advanced that their treatment can penetrate deeply into inflamed tissues and joints that conventional antibodies cannot reach\u2014like having a microscopic key that unlocks previously inaccessible disease mechanisms!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 MoonLake Immunotherapeutics Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 29, 2025, MoonLake Immunotherapeutics (MLTX) trades at <strong>$55.42<\/strong> per share. But mark your calendar\u2014<strong>September 2025<\/strong> is absolutely critical for this stock. That&#8217;s when the company expects the primary endpoint readout from its Phase 3 VELA trial in hidradenitis suppurativa (<a href=\"https:\/\/www.stocktitan.net\/news\/MLTX\/moon-lake-immunotherapeutics-reports-second-quarter-2025-financial-oxqqfyssxfsh.html\">Q2 2025 Financial Report<\/a>).<\/p>\n<h3>How Clinical Trial Results Move MLTX Stock<\/h3>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Jun 3, 2025<\/td>\n<td>Positive Trial Results<\/td>\n<td>~$45<\/td>\n<td><strong>+19.21%<\/strong> (1 week)<\/td>\n<\/tr>\n<tr>\n<td>Aug 5, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$52.40<\/td>\n<td><strong>+5.8%<\/strong> (current rally)<\/td>\n<\/tr>\n<tr>\n<td>Previous<\/td>\n<td>FDA Fast Track<\/td>\n<td>$38<\/td>\n<td><strong>+22%<\/strong> (monthly gain)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The pattern is clear: positive clinical developments create massive momentum for MLTX. The upcoming September readout could be the biggest catalyst yet.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6-Month Price Journey: From Volatility to Strength<\/h2>\n<p>MLTX has been on an incredible ride over the past six months:<\/p>\n<table>\n<thead>\n<tr>\n<th>Month<\/th>\n<th>Price Range<\/th>\n<th>Key Development<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>March 2025<\/td>\n<td>$42-48<\/td>\n<td>Early trial optimism<\/td>\n<\/tr>\n<tr>\n<td>April 2025<\/td>\n<td>$45-50<\/td>\n<td>Capital raise completed<\/td>\n<\/tr>\n<tr>\n<td>May 2025<\/td>\n<td>$48-52<\/td>\n<td>Phase 3 enrollment milestones<\/td>\n<\/tr>\n<tr>\n<td>June 2025<\/td>\n<td>$50-55<\/td>\n<td>Positive interim data<\/td>\n<\/tr>\n<tr>\n<td>July 2025<\/td>\n<td>$52-58<\/td>\n<td>Analyst upgrades<\/td>\n<\/tr>\n<tr>\n<td>August 2025<\/td>\n<td>$54-56<\/td>\n<td>Pre-readout consolidation<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The stock has gained approximately <strong>32%<\/strong> from its March lows, showing consistent upward momentum despite typical biotech volatility.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current clinical progress and analyst consensus, here&#8217;s what to expect:<\/p>\n<p><strong>2025 Year-End<\/strong>: $74-85 (BLA submission anticipation) \u2192 <strong>STRONG BUY<\/strong><br \/> <strong>2026<\/strong>: $95-120 (Potential FDA approval)<br \/> <strong>2028<\/strong>: $180-250 (Commercial ramp-up)<br \/> <strong>2030<\/strong>: $300-400+ (Market leadership position)<\/p>\n<p>Analysts maintain a <a href=\"https:\/\/stockanalysis.com\/stocks\/mltx\/\">Strong Buy rating with average target of $74.83<\/a>, representing 35% upside from current levels.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>Clinical trial failure<\/strong> &#8211; Phase 3 results could disappoint<\/li>\n<li><strong>Regulatory delays<\/strong> &#8211; FDA approval process uncertainties<\/li>\n<li><strong>Cash burn<\/strong> &#8211; $49.8M quarterly R&#038;D spending (<a href=\"https:\/\/www.stocktitan.net\/news\/MLTX\/moon-lake-immunotherapeutics-reports-second-quarter-2025-financial-oxqqfyssxfsh.html\">Q2 2025 Report<\/a>)<\/li>\n<li><strong>Competition<\/strong> &#8211; Other IL-17 inhibitors in development<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>$425M cash + $500M financing<\/strong> &#8211; Runway into 2028<\/li>\n<li><strong>September catalyst<\/strong> &#8211; Phase 3 readout imminent<\/li>\n<li><strong>Analyst consensus<\/strong> &#8211; 14 Strong Buy ratings<\/li>\n<li><strong>Market position<\/strong> &#8211; First tri-specific nanobody therapy<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start small<\/strong> &#8211; Allocate only what you can afford to lose in high-volatility biotech<\/li>\n<li><strong>Watch September<\/strong> &#8211; Wait for Phase 3 results before major commitments<\/li>\n<li><strong>Dollar-cost average<\/strong> &#8211; Build position gradually over months<\/li>\n<li><em>Humorous veteran advice<\/em>: &#8220;Trading MLTX is like dating a brilliant scientist\u2014thrilling potential, but prepare for unexpected experiments!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 How to Buy MoonLake Immunotherapeutics (MLTX) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose trading platform<\/td>\n<td>Ensure NASDAQ access and low fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account funding<\/td>\n<td>Start with manageable amount<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search &#8220;MLTX&#8221;<\/td>\n<td>Use exact ticker symbol<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Set limit order<\/td>\n<td>Avoid market orders during volatility<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Confirm purchase<\/td>\n<td>Review commission costs<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Monitor position<\/td>\n<td>Set price alerts for news events<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Plan exit strategy<\/td>\n<td>Know your profit targets and stop-losses<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Makes Biotech Investing Accessible<\/h2>\n<p>For new investors interested in companies like MoonLake, Pocket Option offers exceptional advantages:<\/p>\n<ul>\n<li><strong>Minimum deposit just $5<\/strong> &#8211; Perfect for testing strategies with biotech volatility<\/li>\n<li><strong>Instant verification<\/strong> &#8211; Single document KYC gets you trading immediately<\/li>\n<li><strong>100+ withdrawal methods<\/strong> &#8211; Flexibility for international investors<\/li>\n<li><strong>Fractional shares<\/strong> &#8211; Own part of high-priced stocks like MLTX<\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface makes complex biotech investing approachable for beginners while providing advanced tools for experienced traders.<\/p>\n<h2>\ud83c\udf0d MoonLake in 2025: Immunology&#8217;s Rising Star<\/h2>\n<p>MoonLake Immunotherapeutics stands at the forefront of medical innovation with its revolutionary nanobody technology. The company&#8217;s lead candidate, Sonelokimab, represents a breakthrough approach to treating inflammatory diseases by targeting both IL-17A and IL-17F simultaneously (<a href=\"https:\/\/moonlaketx.com\/about-us\/\">Company Overview<\/a>).<\/p>\n<p>With a market capitalization of $3.48 billion and robust financial backing, MoonLake has positioned itself as a serious contender in the competitive immunology space. The company&#8217;s upcoming Phase 3 readout could potentially transform treatment paradigms for millions suffering from hidradenitis suppurativa and other inflammatory conditions.<\/p>\n<p><strong>Interesting Fact<\/strong>: MoonLake&#8217;s nanobody technology is so advanced that their treatment can penetrate deeply into inflamed tissues and joints that conventional antibodies cannot reach\u2014like having a microscopic key that unlocks previously inaccessible disease mechanisms!<\/p>\n"},"faq":[{"question":"What is MoonLake Immunotherapeutics' main product?","answer":"Sonelokimab, a tri-specific nanobody targeting IL-17A and IL-17F for inflammatory diseases."},{"question":"When is the next major catalyst for MLTX stock?","answer":"September 2025 Phase 3 clinical trial readout for hidradenitis suppurativa."},{"question":"Is MLTX profitable yet?","answer":"No, like most clinical-stage biotechs, they're investing heavily in R&D with negative earnings currently."},{"question":"What's the biggest risk for MoonLake investors?","answer":"Clinical trial failure\u2014negative Phase 3 results could significantly impact the stock price."},{"question":"How much cash does MoonLake have for operations?","answer":"$425.1 million plus $500 million in non-dilutive financing, providing runway into 2028."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is MoonLake Immunotherapeutics' main product?","answer":"Sonelokimab, a tri-specific nanobody targeting IL-17A and IL-17F for inflammatory diseases."},{"question":"When is the next major catalyst for MLTX stock?","answer":"September 2025 Phase 3 clinical trial readout for hidradenitis suppurativa."},{"question":"Is MLTX profitable yet?","answer":"No, like most clinical-stage biotechs, they're investing heavily in R&D with negative earnings currently."},{"question":"What's the biggest risk for MoonLake investors?","answer":"Clinical trial failure\u2014negative Phase 3 results could significantly impact the stock price."},{"question":"How much cash does MoonLake have for operations?","answer":"$425.1 million plus $500 million in non-dilutive financing, providing runway into 2028."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy MoonLake Immunotherapeutics (MLTX) shares - Investment in MoonLake Immunotherapeutics (MLTX) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy MoonLake Immunotherapeutics (MLTX) shares - Investment in MoonLake Immunotherapeutics (MLTX) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T10:02:00+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy MoonLake Immunotherapeutics (MLTX) shares &#8211; Investment in MoonLake Immunotherapeutics (MLTX) stock\",\"datePublished\":\"2025-08-29T10:02:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\",\"name\":\"How to buy MoonLake Immunotherapeutics (MLTX) shares - Investment in MoonLake Immunotherapeutics (MLTX) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"datePublished\":\"2025-08-29T10:02:00+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy MoonLake Immunotherapeutics (MLTX) shares &#8211; Investment in MoonLake Immunotherapeutics (MLTX) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy MoonLake Immunotherapeutics (MLTX) shares - Investment in MoonLake Immunotherapeutics (MLTX) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/","og_locale":"en_US","og_type":"article","og_title":"How to buy MoonLake Immunotherapeutics (MLTX) shares - Investment in MoonLake Immunotherapeutics (MLTX) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T10:02:00+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy MoonLake Immunotherapeutics (MLTX) shares &#8211; Investment in MoonLake Immunotherapeutics (MLTX) stock","datePublished":"2025-08-29T10:02:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/","name":"How to buy MoonLake Immunotherapeutics (MLTX) shares - Investment in MoonLake Immunotherapeutics (MLTX) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","datePublished":"2025-08-29T10:02:00+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy MoonLake Immunotherapeutics (MLTX) shares &#8211; Investment in MoonLake Immunotherapeutics (MLTX) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":357240,"slug":"how-to-buy-moonlake-immunotherapeutics","post_title":"Comment acheter des actions MoonLake Immunotherapeutics (MLTX) - Investir dans l'action MoonLake Immunotherapeutics (MLTX)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"},"it_IT":{"locale":"it_IT","id":357245,"slug":"how-to-buy-moonlake-immunotherapeutics","post_title":"Come acquistare azioni MoonLake Immunotherapeutics (MLTX) - Investire in azioni MoonLake Immunotherapeutics (MLTX)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"},"pl_PL":{"locale":"pl_PL","id":357241,"slug":"how-to-buy-moonlake-immunotherapeutics","post_title":"Jak kupi\u0107 akcje MoonLake Immunotherapeutics (MLTX) - Inwestycja w akcje MoonLake Immunotherapeutics (MLTX)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"},"es_ES":{"locale":"es_ES","id":357242,"slug":"how-to-buy-moonlake-immunotherapeutics","post_title":"C\u00f3mo comprar acciones de MoonLake Immunotherapeutics (MLTX) - Inversi\u00f3n en acciones de MoonLake Immunotherapeutics (MLTX)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"},"th_TH":{"locale":"th_TH","id":357244,"slug":"how-to-buy-moonlake-immunotherapeutics","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 MoonLake Immunotherapeutics (MLTX) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 MoonLake Immunotherapeutics (MLTX)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"},"tr_TR":{"locale":"tr_TR","id":357243,"slug":"how-to-buy-moonlake-immunotherapeutics","post_title":"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"},"vt_VT":{"locale":"vt_VT","id":357239,"slug":"how-to-buy-moonlake-immunotherapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu MoonLake Immunotherapeutics (MLTX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu MoonLake Immunotherapeutics (MLTX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"},"pt_AA":{"locale":"pt_AA","id":357238,"slug":"how-to-buy-moonlake-immunotherapeutics","post_title":"Como comprar a\u00e7\u00f5es da MoonLake Immunotherapeutics (MLTX) - Investimento em a\u00e7\u00f5es da MoonLake Immunotherapeutics (MLTX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/357174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=357174"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/357174\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334126"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=357174"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=357174"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=357174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}